Direkt zum Inhalt

Heft Nr. 4

4. November 2021

Branchenwort
Innovation in der Life Science und Healthcare Industrie - Quo Vadis?
S. 195
🔓︎ Free Access
Aufsätze
Challenges and Opportunities in Licensing Biotech-Research Tools
S. 199
Keywords: Licensing, Research Privilege, Compulsory Licenses, Research Tools, CRISPR/CAS, Gene editing, AlphaFold
Value-Based Pricing Agreements for Hospital Medicines
S. 208
Keywords: value-based pricing, reimbursement
A Practitioner's Guide Through the Swiss Privacy Landscape in the Health Sector
S. 213
Keywords: Privacy, Health, Clinical research, Consent
Ruptures d'Approvisionnement de Médicaments sous Contrôle
S. 225
Keywords: médicament, stupéfiants pénurie, importations notifications, Swissmedic, OFSP
Swiss access to EU market - protected by law, endangered by politics?
S. 245
Keywords:Medical Devices, Medical Devices Regulation, Mutual Recognition Agreement, MRA, Notice to Stakeholders, notified bodies, Swiss Legacy Devices, bilateral agreements, MRA, Medical Devices Directive, MDD, GATT, WTO , European Commission
Medical Cannabis in Switzerland
S. 257
Keywords:Cannabis, New Regulation
Gesetzgebung
Das revidierte Datenschutzgesetz
S. 264
Keywords: Datenschutz, Gesundheitsdaten, DSG-Revision
Literaturhinweise
Literatur
S. 270
Veranstaltungen
Veranstaltungen
S. 271
🔓︎ Free Access